Serum progesterone
Progesterone blood test (serum)Serum progesterone is a test to measure the amount of progesterone in the blood. Progesterone is a hormone produced mainly in the ovaries.
Progesterone plays a key role in pregnancy. It is produced after ovulation in the second half of the menstrual cycle. It helps make a woman's uterus ready for a fertilized egg to be implanted. It also prepares the uterus for pregnancy by inhibiting the uterine muscle to contract and prepares the breasts for milk production.
How the Test is Performed
A blood sample is needed. Most of the time, blood is drawn from a vein located on the inside of the elbow or the back of the hand.
Drawn from a vein
Venipuncture is the collection of blood from a vein. It is most often done for laboratory testing.
Read Article Now Book Mark ArticleHow to Prepare for the Test
Many medicines can interfere with blood test results.
- Your health care provider will tell you if you need to stop taking any medicines before you have this test.
- DO NOT stop or change your medicines without talking to your provider first.
How the Test will Feel
You may feel slight pain or a sting when the needle is inserted. You may also feel some throbbing at the site after the blood is drawn.
Why the Test is Performed
This test is done to:
- Determine if a woman is currently ovulating or has recently ovulated
- Evaluate a woman with repeated miscarriages (other tests are used more commonly)
- Determine the risk for miscarriage or ectopic pregnancy early in pregnancy, (now largely superseded by other diagnostic options)
Normal Results
Progesterone levels vary, depending on the timing when the test is done. Blood progesterone levels start to rise midway through the menstrual cycle. It continues to rise for about 6 to 10 days, and then falls if the egg is not fertilized.
Levels continue to rise in early pregnancy.
The following are normal ranges based upon certain phases of the menstrual cycle and pregnancy:
- Female (pre-ovulation): less than 1 nanogram per milliliter (ng/mL) or 3.18 nanomoles per liter (nmol/L)
- Female (mid-cycle): 5 to 20 ng/mL or 15.90 to 63.60 nmol/L
- Male: less than 1 ng/mL or 3.18 nmol/L
- Postmenopausal: less than 1 ng/mL or 3.18 nmol/L
- Pregnancy 1st trimester: 11.2 to 90.0 ng/mL or 35.62 to 286.20 nmol/L
- Pregnancy 2nd trimester: 25.6 to 89.4 ng/mL or 81.41 to 284.29 nmol/L
- Pregnancy 3rd trimester: 48 to 150 to 300 or more ng/mL or 152.64 to 477 to 954 or more nmol/L
Normal value ranges may vary slightly among different laboratories. Talk to your provider about the meaning of your specific test results.
The examples above show the common measurements for results for these tests. Some laboratories use different measurements.
What Abnormal Results Mean
Higher-than-normal levels may be due to:
- Pregnancy
- Ovulation
- Adrenal cancer (rare)
- Ovarian cancer (rare)
Ovarian cancer
Ovarian cancer is cancer that starts in the ovaries. The ovaries are the female reproductive organs that produce eggs.
Read Article Now Book Mark Article - Congenital adrenal hyperplasia (rare)
Congenital adrenal hyperplasia
Congenital adrenal hyperplasia is the name given to a group of inherited disorders of the adrenal gland. Inherited means the traits are passed down ...
Read Article Now Book Mark Article
Lower-than-normal levels may be due to:
- Amenorrhea (no periods as result of anovulation [ovulation does not occur])
- Ectopic pregnancy
Ectopic pregnancy
An ectopic pregnancy is a pregnancy that occurs outside the womb (uterus).
Read Article Now Book Mark Article - Irregular periods
- Fetal death
Fetal death
A miscarriage is the spontaneous loss of a fetus before the 20th week of pregnancy. Pregnancy losses after the 20th week are called stillbirths. Mi...
Read Article Now Book Mark Article - Miscarriage
References
Bulun SE. Physiology and pathology of the female reproductive axis. In: Melmed S, Auchus, RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Williams Textbook of Endocrinology. 14th ed. Philadelphia, PA: Elsevier; 2020:chap 17.
Humphreys MA, Branch DW. Recurrent pregnancy loss. In: Lockwood CJ, Copel JA, Dugoff L, Louis J, Silver RM, Resnik R, eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 9th ed. Philadelphia, PA: Elsevier; 2023:chap 41.
Review Date: 4/1/2023
Reviewed By: John D. Jacobson, MD, Professor Emeritus, Department of Obstetrics and Gynecology, Loma Linda University School of Medicine, Loma Linda, CA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.